WAM
SCLN

Wolverine Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Wolverine Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-549,765
Closed -$6.16M – 1718
2017
Q3 		$6.16M Buy
549,765
+320,558
+140% +$3.54M 0.07% 220
2017
Q2 		$2.52M Buy
+229,207
New +$2.29M 0.03% 384

Wolverine Asset Management's SCLN Position: Q4 2017 in Review

Wolverine Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 549,765 shares — an estimated $6.16M sold.

Wolverine Asset Management first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $6.16M in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Wolverine Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Wolverine Asset Management sold 549,765 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $6.16M.
  • Wolverine Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • Wolverine Asset Management's Sciclone Pharmaceuticals Inc position peaked at $6.16M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Wolverine Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.